Precision Medicine in Cancers and Non-Communicable Diseases

ISBN-13: 9781498775601 / Angielski / Twarda / 2018 / 326 str.

Debmalya Barh

Opis

We are entering the era of clinical practice of -precision medicine- from the age of -personalized medicine.- This book will provide the latest approaches in prediction, diagnosis, prevention and management of all major diseases based on genotype, inflecting environmental factors and lifestyle of a person. All recent developments have been explained along with epidemiology, technologies, and approaches to manage the included diseases. Therefore, readers will get the up-to-date information on the next-generation approach in tackling these life-threatening diseases.

Spis treści

1. Precision Medicine in Oncology: An overview. 2. Circulating tumor cells and circulating tumor DNA in precision medicine. 3. Oral Squamous Cell Carcinoma and liquid biopsies: a new tool for precision oncology. 4. Precision medicine for brain gliomas. 5. Precision Medicine for Colorectal Cancer. 6. Precision medicine in prostate cancer. 7. Breast cancer epigenetic targets for precision medicine. 8. Precision medicine in Ovarian Carcinoma. 9. Precision Medicine in Myelodysplastic Syndromes. 10. Precision Medicine in Acute Myeloid Leukemia. 11. Precision medicine in Coronary Artery Disease. 12. Precision Medicine in Stroke and other related Neurological Diseases. 13. Precision medicine in osteoporosis and bone diseases. 14. Precision medicine in diabetes mellitus. 15. Precision medicine in multiple sclerosis. 16. Precision Medicine in asthma and COPD. 17. Customized DNA Directed Precision Nutrition to Balance the Brain Reward Circuitry and Reduce Addictive Behaviours.   

O autorze

Debmalya Barh, MSc, MTech, MPhil, PhD, PGDM, is the Founder and Principal Scientist of Institute of Integrative Omics and Applied Biotechnology (IIOAB), INDIA. He is having 12+ years leading academic, healthcare, molecular diagnostic, and bioinformatics industry experience and an expert in integrative omics–based biomarkers, targets and targeted drug discovery, and personalized medicine in cancers and various complex diseases. He works with more than 400 scientists from 100+ top ranked organizations across 40+ countries and has 150+ publications and a branded editor for 10+ cutting-edge omics related reference books. He is a reviewer of journals from Nature publications, Elsevier and AACR Journals, CMAJ, NAR, Molecular Medicine, Gene Therapy, BMC Series, Bioinformatics, PLOS etc. Due to his significant contribution in the field; he has been recognized by Who's Who in the World and Limca Book of Records.